Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematinics | 1 | 2023 | 55 | 0.800 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2023 | 133 | 0.700 |
Why?
|
| STAT6 Transcription Factor | 2 | 2017 | 33 | 0.630 |
Why?
|
| Fibroblasts | 4 | 2017 | 891 | 0.560 |
Why?
|
| Kidney | 4 | 2017 | 1352 | 0.520 |
Why?
|
| Arginine Vasopressin | 1 | 2016 | 28 | 0.520 |
Why?
|
| Janus Kinase 3 | 1 | 2015 | 16 | 0.490 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2020 | 727 | 0.480 |
Why?
|
| Pyrroles | 1 | 2015 | 179 | 0.440 |
Why?
|
| Piperidines | 1 | 2015 | 205 | 0.430 |
Why?
|
| Cerebral Angiography | 1 | 2013 | 102 | 0.410 |
Why?
|
| Brain Edema | 1 | 2013 | 69 | 0.400 |
Why?
|
| Renal Dialysis | 4 | 2023 | 854 | 0.400 |
Why?
|
| Pyrimidines | 1 | 2015 | 372 | 0.390 |
Why?
|
| Carotid Artery Diseases | 1 | 2013 | 147 | 0.380 |
Why?
|
| Aneurysm, False | 1 | 2013 | 105 | 0.370 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 530 | 0.360 |
Why?
|
| Kidney Failure, Chronic | 2 | 2019 | 880 | 0.340 |
Why?
|
| Contrast Media | 1 | 2013 | 471 | 0.320 |
Why?
|
| Hip Fractures | 2 | 2020 | 67 | 0.310 |
Why?
|
| Receptors, CXCR | 2 | 2014 | 7 | 0.230 |
Why?
|
| Glucaric Acid | 1 | 2023 | 10 | 0.210 |
Why?
|
| Ferric Compounds | 1 | 2023 | 37 | 0.210 |
Why?
|
| Fibrosis | 5 | 2017 | 436 | 0.210 |
Why?
|
| Myofibroblasts | 4 | 2015 | 75 | 0.200 |
Why?
|
| Bone Marrow Transplantation | 4 | 2017 | 578 | 0.170 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2017 | 154 | 0.170 |
Why?
|
| Blood Pressure | 2 | 2023 | 1350 | 0.160 |
Why?
|
| Kidney Diseases | 2 | 2014 | 481 | 0.160 |
Why?
|
| Fibronectins | 2 | 2015 | 104 | 0.140 |
Why?
|
| Collagen Type I | 2 | 2015 | 112 | 0.140 |
Why?
|
| Actins | 2 | 2017 | 342 | 0.130 |
Why?
|
| Monocytes | 2 | 2017 | 354 | 0.130 |
Why?
|
| Glycopeptides | 1 | 2016 | 25 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 410 | 0.130 |
Why?
|
| Bone Marrow Cells | 1 | 2017 | 261 | 0.130 |
Why?
|
| Mice, Knockout | 4 | 2017 | 3753 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 471 | 0.120 |
Why?
|
| Interleukin-4 | 1 | 2015 | 139 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 435 | 0.120 |
Why?
|
| Interleukin-13 | 1 | 2015 | 96 | 0.120 |
Why?
|
| Ureteral Obstruction | 1 | 2015 | 105 | 0.110 |
Why?
|
| Angiotensin II | 1 | 2014 | 163 | 0.110 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2013 | 8 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 393 | 0.100 |
Why?
|
| Blood-Brain Barrier | 1 | 2013 | 145 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2015 | 4428 | 0.090 |
Why?
|
| Depression | 1 | 2019 | 1243 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2012 | 421 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 2013 | 224 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2019 | 3436 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2015 | 3061 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2017 | 4542 | 0.080 |
Why?
|
| Apoptosis | 1 | 2015 | 1791 | 0.080 |
Why?
|
| Mice | 5 | 2017 | 17743 | 0.070 |
Why?
|
| Male | 8 | 2020 | 61306 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1894 | 0.070 |
Why?
|
| Biomarkers | 1 | 2016 | 3063 | 0.070 |
Why?
|
| Humans | 7 | 2023 | 124809 | 0.070 |
Why?
|
| Hypertension | 1 | 2014 | 1316 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 2091 | 0.060 |
Why?
|
| Receptors, CXCR6 | 2 | 2014 | 14 | 0.060 |
Why?
|
| Chemokine CXCL6 | 2 | 2014 | 16 | 0.050 |
Why?
|
| Animals | 5 | 2017 | 34188 | 0.050 |
Why?
|
| Middle Aged | 3 | 2020 | 26727 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 4355 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 6522 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 2410 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 503 | 0.030 |
Why?
|
| Th2 Cells | 1 | 2017 | 185 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 1811 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 1007 | 0.030 |
Why?
|
| Folic Acid | 1 | 2017 | 292 | 0.030 |
Why?
|
| Chemokine CXCL16 | 1 | 2014 | 10 | 0.030 |
Why?
|
| Albuminuria | 1 | 2014 | 98 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 121 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2014 | 103 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 3288 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 241 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2012 | 101 | 0.020 |
Why?
|
| Incidence | 1 | 2019 | 3144 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 19693 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2052 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5155 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 618 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 4615 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 543 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 1569 | 0.020 |
Why?
|
| Cytokines | 1 | 2014 | 1290 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1929 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 1709 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 10274 | 0.020 |
Why?
|
| United States | 1 | 2019 | 10875 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 6312 | 0.010 |
Why?
|
| Female | 2 | 2020 | 66575 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 16294 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 29482 | 0.010 |
Why?
|